Key facts
- This page summarizes Jonathan Bornstein's Form 4 filing for Amprius Technologies, Inc. (AMPX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Mar 2024, 19:32.
Jonathan Bornstein - 19 Mar 2024 Form 4 Insider Report for Amprius Technologies, Inc. (AMPX)
- Reporting relationship
- President of Amprius Lab
- Issuer ticker
- AMPX
- Reported as of
- 19 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2024, 19:32:17 UTC
- Prior SEC filing
- 07 Mar 2024
- Next SEC filing
- 03 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra Wallach, attorney-in-fact on behalf of Jonathan Bornstein
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan Bornstein filed Form 4 for Amprius Technologies, Inc. (AMPX) on 19 Mar 2024.
Change
- Previous filing in this sequence was filed on 07 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMPX
transaction
Common stock
Award
- Transaction value
- $0
- Shares
- +558,930
- Change %
- Price
- $0.000000
- Shares after
- 558,930
- Date
- 19 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The securities are represented by restricted stock units. Each restricted stock unit represents the reporting person's right to receive one share of the issuer's common stock. 1/16th of shares subject to award will vest on May 20, 2024 and quarterly thereafter on each August 20, November 20, February 20 and May 20, subject to the reporting person's continued service on each such date, until the award is fully vested on February 20, 2028.
Footnote F2
Includes 558,930 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.